R. Amaro Rodriguez (Premia de Dalt (Barcelona), Spain), A. Shoemark (Dundee (Angus), United Kingdom)
PHENOTYPIC CLUSTERING IN NON-CYSTIC FIBROSIS BRONCHIECTASIS PATIENTS: THE ROLE OF NEUTROPHILS IN DISEASE SEVERITY
X. Wang (Barcelona, Spain), C. Villa (Barcelona, Spain), Y. Dobarganes (Barcelona, Spain), C. Olveira (Barcelona, Spain), R. Girón (Barcelona, Spain), M. García-Clemente (Barcelona, Spain), . Máiz Carro (Barcelona, Spain), O. Sibila (Barcelona, Spain), R. Golpe (Barcelona, Spain), R. Menéndez (Barcelona, Spain), J. Rodríguez-López (Barcelona, Spain), C. Prados (Barcelona, Spain), M. Martinez-García (Barcelona, Spain), J. Luis Rodriguez (Barcelona, Spain), D. De La Rosa (Barcelona, Spain), X. Duran (Barcelona, Spain), J. Garcia-Ojalvo (Barcelona, Spain), E. Barreiro (Barcelona, Spain)
|   |
Clinical characteristics and imaging of adult PCD patients: a single-center experience.
C. Kosti (Athens, Greece), V. Tzilas (Athens, Greece), A. Digalaki (Athens, Greece), S. Koukidou (Athens, Greece), I. Tomos (Athens, Greece), G. Hillas (Athens, Greece), S. Chrysikos (Athens, Greece), E. Zervou (Athens, Greece), K. Dimakou (Athens, Greece), A. Digalaki (Athens, Greece)
| |
Clinical, radiological and bacteriological profile of patients with Bronchiectasis and asthma coexistence.
A. Digalaki (Athens, Greece), S. Koukidou (Athens, Greece), G. Hillas (Athens, Greece), C. Kosti (Athens, Greece), S. Chrysikos (Athens, Greece), A. Sakellaropoulou (Athens, Greece), K. Dimakou1 (Athens, Greece)
| |
Use of multidimensional scales to predict outcomes in admissions due to bronchiectasis exacerbation.
B. Urrutia Royo (Barcelona, Spain), M. Compte Vives (Badalona, Spain), I. García-Olivé (Badalona, Spain), C. Folgado López (Badalona, Spain), J. Abad Capa (Badalona, Spain), A. Rosell Gratacós (Badalona, Spain)
| |
Demographic and clinical features of Swedish patients with bronchiectasis; preliminary results from a tertiary EMBARC centre.
P. Ghosh (Stockholm, Sweden), I. Gerhardson (Stockholm, Sweden), N. Bedi (Stockholm, Sweden), S. Barsch Cornacchini (Stockholm, Sweden), N. Lazarinis (Stockholm, Sweden), B. Dahlen (Stockholm, Sweden), J. Chalmers (Dundee, United Kingdom), A. Bossios (Stockholm, Sweden)
| |
Primary ciliary dyskinesia in Volendam: diagnostic and phenotypic features in patients with a CCDC114 mutation
R. Kos (Amsterdam, Netherlands), J. Israëls (Amsterdam, Netherlands), C. Van Gogh (Amsterdam, Netherlands), J. Altenburg (Amsterdam, Netherlands), S. Diepenhorst (Amsterdam, Netherlands), T. Paff (Amsterdam, Netherlands), E. Boon (Amsterdam, Netherlands), G. Pals (Amsterdam, Netherlands), A. Neerincx (Amsterdam, Netherlands), A. Maitland-Van Der Zee (Amsterdam, Netherlands), E. Haarman (Amsterdam, Netherlands), E. Haarman (Amsterdam, Netherlands)
| |
The Bronchiectasis- rhinosinusitis association is characterized by sputum eosinophilia
M. Shteinberg (Haifa, Israel), J. Chalmers (Dundee, United Kingdom), M. Rahat (Haifa, Israel), E. Simanovich (Haifa, Israel), S. Cohen (Haifa, Israel), N. Abu-Hilu (Haifa, Israel), S. Avital (Haifa, Israel), E. Mohammed (Haifa, Israel), J. Gerbshian (Haifa, Israel), N. Stein (Haifa, Israel), S. Schneer (Haifa, Israel), N. Nasrallah (Haifa, Israel), I. Eisenberg (Haifa, Israel), Y. Adir (Haifa, Israel)
| |
Etiology, clinical, radiological and microbiological profile of patients with non-CF bronchiectasis in Tunisia
H. Kwas (Gabes, Tunisia, Tunisia), S. Majdoub (Gabes, Tunisia, Tunisia), W. Medi (Gabes, Tunisia, Tunisia)
| |
Comparison of hospital admissions in people with bronchiectasis between the covid-19 pandemic (2020) and pre-pandemic period (2019)
X. Lin (Zaragoza, Spain), A. García-Esteban (Zaragoza, Spain), G. Loscertales-Vacas (Zaragoza, Spain), M. Martín Lana (Zaragoza, Spain), E. Borobia-Irache (Zaragoza, Spain), A. Aguelo-Velilla (Zaragoza, Spain), B. Herrero Cortina (Zaragoza, Spain)
| |
Imaging analysis of sarcopenia in a cohort of stable patients with bronchiectasis
M. Alvarado Miranda (Barcelona, Spain), A. Nuñez Robainas (Barcelona, Spain), M. Pérez Peiró (Barcelona, Spain), S. Marsico (Barcelona, Spain), A. Solano López (Barcelona, Spain), E. Barreiro (Barcelona, Spain)
| |
Bronchiectasis in Pakistan: A retrospective review of patients with non-cystic fibrosis bronchiectasis at a tertiary care center
S. Shahid (karachi, Pakistan), S. Zubair (karachi, Pakistan), A. Abdul Jabbar (karachi, Pakistan), A. Wagley (karachi, Pakistan), M. Musharraf (karachi, Pakistan), H. Zahid (karachi, Pakistan), M. Irfan (karachi, Pakistan)
| |
PROFILE OF CLINICAL AND ANALYTICAL PARAMETERS IN BRONCHIECTASIS PATIENTS DURING THE COVID-19 PANDEMIC: A ONE-YEAR FOLLOW-UP STUDY.
L. Qin (Barcelona, Spain), F. Gonçalves-Carvalho (Barcelona, Spain), Y. Xia (Barcelona, Spain), J. Zha (Barcelona, Spain), M. Admetlló (Barcelona, Spain), J. Maiques (Barcelona, Spain), S. Esteban-Cucó (Barcelona, Spain), X. Duran (Barcelona, Spain), A. Marín (Barcelona, Spain), E. Barreiro (Barcelona, Spain)
| |
Long-term outcome of nebulised antibiotic prophylaxis in bronchiectasis: a retrospective cohort study
W. Ng (London, United Kingdom), K. Hattotuwa (London, United Kingdom), J. Mulholland (London, United Kingdom), K. Hattotuwa (Chelmsford (Essex), United Kingdom)
| |
Prevalence of eosinophilia in chronic respiratory illness (CRI) during exacerbation with a focus on outcomes related to ICS treatment in Bronchiectasis
I. Rusu (Stoke-on-Trent, United Kingdom), R. Khan (Stoke-on-Trent, United Kingdom), M. Okoh (Stoke-on-Trent, United Kingdom), S. Ekhelikar (Telford, United Kingdom), N. Ahmad (Telford, United Kingdom)
| |
Correlation between radiological scores and clinical and biological data in patients with bronchiectasis
H. Snène (Tunis, Tunisia), M. Guemri (Tunis, Tunisia), S. Debiche (Tunis, Tunisia), H. Blibech (Tunis, Tunisia), S. Daoud (Tunis, Tunisia), L. Kaabi (Tunis, Tunisia), S. Ouali (Tunis, Tunisia), J. Daghfous (Tunis, Tunisia), L. Ben Farhar (Tunis, Tunisia), N. Mehiri (Tunis, Tunisia), N. Ben Salah (Tunis, Tunisia), B. Louzir (Tunis, Tunisia)
| |
CLINICAL CHARACTERISTICS, RADIOLOGICAL FEATURES, AND DISEASE SEVERITY OF BRONCHIECTASIS ACCORDING TO THE SPIROMETRIC PATTERN
B. Yang (Cheongju-si, Republic of Korea), S. Kim (Cheongju-si, Republic of Korea), S. Kim (Cheongju-si, Republic of Korea), J. Cho (Cheongju-si, Republic of Korea), E. Kim (Cheongju-si, Republic of Korea), K. Choe (Cheongju-si, Republic of Korea)
| |
Prevalence of LasB elastase variants from Pseudomonas aeruginosa respiratory isolates and their inhibition by novel LasB inhibitor ANT3273
A. Llanos (Labège, France), C. Lozano (Labège, France), J. Castandet (Labège, France), M. Zalacain (Labège, France), M. Tunney (Belfast, United Kingdom), R. Mairs (Belfast, United Kingdom), G. Einarsson (Belfast, United Kingdom), M. Everett (Labège, France)
| |
Diagnostic value of multiple breath washout in patients with chronic productive cough
N. Ziegahn (Berlin, Germany), C. Pioch (Berlin, Germany), M. Stahl (Berlin, Germany), M. Mall (Berlin, Germany), J. Roehmel (Berlin, Germany)
| |
Host transcriptomic signature for viral and bacterial infection at exacerbation of COPD–The longitudinal PAX-I study
A. Darie (Basel, Switzerland), D. Schumann (Basel, Switzerland), L. Grize (Basel, Switzerland), K. Jahn (Basel, Switzerland), M. Herrmann (Basel, Switzerland), W. Strobel (Basel, Switzerland), H. Hirsch (Basel, Switzerland), M. Tamm (Basel, Switzerland), D. Stolz (Basel, Switzerland)
| |